Unlocking the Middle East for Clinical Trials: The Role of CROs, Regulators and Hospitals

Countries such as Saudi Arabia and the United Arab Emirates are rapidly emerging as credible destinations for global clinical research, supported by national strategies like Saudi Vision 2030 and UAE Centennial 2071. As regulatory frameworks mature and align with international standards such as those from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, collaboration between global sponsors, regional CROs, regulators, and leading hospitals is accelerating the development of a robust clinical trial ecosystem. This session will explore how these partnerships are shaping trial design, regulatory navigation, and patient recruitment, and what sponsors need to understand to successfully run studies in this fast-evolving region.